Professional Documents
Culture Documents
Ucm Dat-1 New
Ucm Dat-1 New
point)
Origin Formulations deals with these products-
Please see: the above mentioned are only the heads. Detailed product basket under the specified
heads are mentioned in the file attached with the mail.
Oppurtunities-
1. Vast scope of doing business due to agreements done and
wide variety of product range.
2. The specialised team is an opportunity for the company’s
growth as together they can increase their turnover.
3. Expansion of more clients in domestic as well as in
international markets.
4. There is a high profit margin in tender business and currently
the company is working in 3 states and therefore can expand in
other states as well.
Threats-
1. With more number of products falling into DPCO regulations,
there is a fixed price that company has to charge which reduces the
profit margin for the company.
2. Hike in raw material prices, which can fluctuate the costing
and profit margins in domestic as well as in the international
markets.
3. Changing guidelines of different countries, will lead to
reframing of dossiers as per the new requirements, which adds on
the hard-work and an additional cost for the company.
PORTER’s Five Force Analysis:
Political Factors:
There are different elements in the political sphere that could have
an impact on pharmaceutical industry such as changing tax
legislation, consumer protection and employment regulations, price
regulations and insurance mandates. For example, a change in tax
policies may call for a strategy adjustment that either takes
advantage of increased government spending for healthcare or
makes allowances for reduced government subsidies. Or, changes
in employment law, like the 2016 legislation that impacted
employee overtime requirements, could mean major adjustments in
staffing and overtime needs.
- Political factors affecting:
Low Trade Restrictions
Skilled Government
Political Stability
Reduced Costs
Experienced Political Environment
Governmental Support
Economical factors:
Economical concerns such as unemployment, inflation, and interest
rates etc. influence both directly and indirectly on the financial
performance of the healthcare industry. These changing conditions
can have an impact on public spending policies and purchasing
power parity. For example, if one manufacture’s healthcare
equipment, a high rate of unemployment will mean fewer people are
able to purchase his products. Or, more people losing jobs means a
greater loss of health insurance coverage, which will affect the
types of health services people seek out.
- Economical aspects for:
Unwavering Economy
Competitive Market
Public Investments in Research and Development
Taxes
Government Expenditure
Social factors:
A social analysis must identify changes in demographics, values,
and beliefs of various consumer groups. For example, a hospital
should know about the community it serves to avoid violating
widespread values or norms. A marketing strategy should be
formulated considering these types of factors also. Using content
that shows that business is associated with a specific socio-cultural
set of beliefs/values will boost the effectiveness of marketing and
impact a positive performance.
- Social aspects for:
Growing Economy
Workforce
New Acquisitions
Education Level
Cultural Diversity
Growing Demand
• Technological
Technological advancements will create new business prospects
both in terms of new therapy systems and service provisions.
Social Media for Healthcare.
Customized Treatments.
Direct to Patient Advertising.
Direct to patient communications.
Also, with technological advancement, there are super-speciality
equipments available, which would help company ease the
manufacturing process and help it in making more systematic.
• Legal
Pharmaceutical industry is a highly regulated industry and the
Company’s operations are subject to extensive regulations in
different markets in which the Company does the business.
In the markets where the Company supplies the products, the
regulatory authorities of those markets must first approve the
product including the manufacturing facility where the product will
be manufactured before the Company can sell the products in those
markets.
Applicable regulations are increasingly becoming stringent
and the penalties for non-compliance with these regulations can be
severe, including the revocation or suspension of licenses and
imposition of fines apart from loss of reputation.
The Company continuously evaluates the quality of its
products, their manufacturing and supply chain processes to ensure
that all the applicable regulations are complied with at all times.
Litigation risk is also very high in pharma industries.
• Environmental
Pharma companies need to see how their business and
marketing plans link in with the environmental issues.
There is also an opportunity to incorporate it within their
Corporate Social Responsibility programmes.
Marketing and new product development should identify
economic opportunities to promote as well.
How will you know that you are right? (Have your validation
criteria set)